Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
18.23
-0.35 (-1.88%)
Dec 31, 2025, 10:52 AM EST - Market open
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $2.34 billion as of December 31, 2025. Its market cap has increased by 97.41% in one year.
Market Cap
2.34B
Enterprise Value
2.30B
1-Year Change
97.41%
Ranking
Category
Stock Price
$18.23
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $2.34B, an increase of 294.23%. That is a compound annual growth rate of 14.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 2.38B | 5.20% |
| Dec 31, 2024 | 2.26B | 1,162.26% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
| Nov 13, 2015 | 593.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |